Harry LeVine

Genetic engineering : a reference handbook

Harry LeVine, 2006 .

The synthesis and structure-activity relationship of substituted N-phenyl anthranilic acid analogs as amyloid aggregation inhibitors.

Harry LeVine, H. Levine, L. Walker, 2009, Bioorganic & medicinal chemistry letters.

Refinement of a homology model of the mu-opioid receptor using distance constraints from intrinsic and engineered zinc-binding sites.

Irina D Pogozheva, Harry LeVine, H. Levine, 2004, Biochemistry.

Corruption and Spread of Pathogenic Proteins in Neurodegenerative Diseases*

Harry LeVine, H. Levine, L. Walker, 2012, The Journal of Biological Chemistry.

The cerebral proteopathies

Harry LeVine, H. Levine, L. Walker, 2000, Neurobiology of Aging.

Alzheimer's Therapeutics Targeting Amyloid Beta 1–42 Oligomers II: Sigma-2/PGRMC1 Receptors Mediate Abeta 42 Oligomer Binding and Synaptotoxicity

Gary Look, Ottavio Arancio, Chenbo Zeng, 2014, PloS one.

Alzheimer's Therapeutics Targeting Amyloid Beta 1–42 Oligomers I: Abeta 42 Oligomer Binding to Specific Neuronal Receptors Is Displaced by Drug Candidates That Improve Cognitive Deficits

Miles Miller, Gary Look, Andrew F. Teich, 2014, PloS one.